Literature DB >> 15133848

Loss of heterozygosity on chromosome 1 in sporadic colorectal carcinoma.

Chong-Zhi Zhou1, Guo-Qiang Qiu, Fang Zhang, Lin He, Zhi-Hai Peng.   

Abstract

AIM: Loss of heterozygosity (LOH) on tumor suppressor genes is believed to play a key role in carcinogenesis of colorectal cancer. When it occurs at a tumor suppressor gene locus with abnormal allele, neoplastic transformation happens. In this study, we analyzed the LOH at 21 loci on chromosome 1 in sporadic colorectal cancer to identify additional loci involved in colorectal tumorigenesis.
METHODS: Twenty-one polymorphic micro-satellite DNA markers were analyzed with PCR both in 83 cases of colorectal cancer and in normal tissues. PCR products were eletrophoresed on an ABI 377 DNA sequencer. Genescan 3.1 and Genotype 2.1 software were used for LOH scanning and analysis. chi2 test was used to compare LOH frequency with clinicopathological data. P<0.05 was considered as statistically significant.
RESULTS: The average LOH frequency of chromosome 1, short arm and long arm was 19.83%, 18.00% and 21.66%, respectively. The 2 highest LOH loci with a frequency of 36.54% and 32.50% were identified on D1S468 (1p36.33-p36.31) and D1S413 (1q31.3), respectively. On D1S2726 locus, LOH frequency of rectal cancer was 28.57% (6/21), which was higher than that of colon cancer (0.00%, 0/33) (P=0.002), suggesting that the mechanism of carcinogenesis was different in both groups.
CONCLUSION: Putative tumor suppressor genes on chromosome 1 may relate to sporadic colorectal carcinomas. Tumor-suppressor-genes might locate on 1p36.33-36.31 and/or 1q31.3.

Entities:  

Mesh:

Year:  2004        PMID: 15133848      PMCID: PMC4656279          DOI: 10.3748/wjg.v10.i10.1431

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

2.  Aberration of p53 and DCC in gastric and colorectal cancer.

Authors:  M Kataoka; T Okabayashi; H Johira; S Nakatani; A Nakashima; A Takeda; M Nishizaki; K Orita; N Tanaka
Journal:  Oncol Rep       Date:  2000 Jan-Feb       Impact factor: 3.906

3.  Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers.

Authors:  S Nomoto; N Haruki; Y Tatematsu; H Konishi; T Mitsudomi; T Takahashi; T Takahashi
Journal:  Genes Chromosomes Cancer       Date:  2000-07       Impact factor: 5.006

4.  A region of allelic imbalance in 1q31-32 in primary breast cancer coincides with a recombination hot spot.

Authors:  J Benítez; A Osorio; A Barroso; E Arranz; M A Díaz-Guillén; M Robledo; S Rodríguez de Córdoba; D Heine-Suñer
Journal:  Cancer Res       Date:  1997-10-01       Impact factor: 12.701

5.  Deletion mapping defines different regions in 1p34.2-pter that may harbor genetic information related to human colorectal cancer.

Authors:  C Praml; L H Finke; C Herfarth; P Schlag; M Schwab; L Amler
Journal:  Oncogene       Date:  1995-10-05       Impact factor: 9.867

6.  Loss of heterozygosity on long arm of chromosome 22 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Zhi-Hai Peng; Fang Zhang; Guo-Qiang Qiu; Lin He
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

7.  Refinement of heterozygosity loss on chromosome 5p15 in sporadic colorectal cancer.

Authors:  Shi-Feng Xu; Zhi-Hai Peng; Da-Peng Li; Guo-Qiang Qiu; Fang Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

Review 8.  Genetic instabilities in human cancers.

Authors:  C Lengauer; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

Authors:  P S White; J M Maris; C Beltinger; E Sulman; H N Marshall; M Fujimori; B A Kaufman; J A Biegel; C Allen; C Hilliard; M B Valentine; A T Look; H Enomoto; S Sakiyama; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

10.  Mutational analysis of the p73 gene localized at chromosome 1p36.3 in colorectal carcinomas.

Authors:  M Sunahara; S Ichimiya; Y Nimura; N Takada; S Sakiyama; Y Sato; S Todo; W Adachi; J Amano; A Nakagawara
Journal:  Int J Oncol       Date:  1998-08       Impact factor: 5.650

View more
  13 in total

Review 1.  Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins.

Authors:  Alea A Mills
Journal:  Nat Rev Cancer       Date:  2010-10       Impact factor: 60.716

2.  The impact of genomic alterations on the transcriptome: a prostate cancer cell line case study.

Authors:  J Chaudhary; M Schmidt
Journal:  Chromosome Res       Date:  2006-07-12       Impact factor: 5.239

3.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

4.  The tumor suppressor Chd5 is induced during neuronal differentiation in the developing mouse brain.

Authors:  Assaf Vestin; Alea A Mills
Journal:  Gene Expr Patterns       Date:  2013-10-09       Impact factor: 1.224

5.  Reduced expression of beta-catenin inhibitor Chibby in colon carcinoma cell lines.

Authors:  Marion M Schuierer; Elisabeth Graf; Ken-Ichi Takemaru; Wolfgang Dietmaier; Anja-Katrin Bosserhoff
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

6.  DPEP1, expressed in the early stages of colon carcinogenesis, affects cancer cell invasiveness.

Authors:  Yuji Toiyama; Yasuhiro Inoue; Hiromi Yasuda; Susumu Saigusa; Takeshi Yokoe; Yoshinaga Okugawa; Koji Tanaka; Chikao Miki; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2010-09-08       Impact factor: 7.527

7.  Loss of heterozygosity at 1p, 7q, 17p, and 22q in meningiomas.

Authors:  In Bok Chang; Byung Moon Cho; Seung Myung Moon; Se Hyuck Park; Sae Moon Oh; Seong Jin Cho
Journal:  J Korean Neurosurg Soc       Date:  2010-07-31

8.  Epigenetic inactivation of the NORE1 gene correlates with malignant progression of colorectal tumors.

Authors:  Chang Kyun Lee; Jin-Hee Lee; Min-Goo Lee; Seong-In Jeong; Tae-Kyu Ha; Min-Ju Kang; Byung-Kyu Ryu; Young Hwangbo; Jae-Jun Shim; Jae Young Jang; Kil Yeon Lee; Hyo Jong Kim; Sung-Gil Chi
Journal:  BMC Cancer       Date:  2010-10-22       Impact factor: 4.430

9.  Refined mapping of loss of heterozygosity on 1q31.1-32.1 in sporadic colorectal carcinoma.

Authors:  Chong-Zhi Zhou; Guo-Qiang Qiu; Jun-Wei Fan; Xiao-Liang Wang; Hua-Mei Tang; Li Huang; Yu-Hao Sun; Zhi-Hai Peng
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

Review 10.  The quest for the 1p36 tumor suppressor.

Authors:  Anindya Bagchi; Alea A Mills
Journal:  Cancer Res       Date:  2008-04-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.